Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

Elsevier
Publish with us

Participate

Abstract Submission Deadline: 2 May 2025

Oral and paper abstracts are now invited on the following topics. They should be submitted using the online abstract submission system opens in new tab/window.

Conference Topics

  • Computational Design of New Vaccines (AI): AI Approaches in Vaccine Development

  • Vaccines against STIs

  • Controlled Human Infection Models in Vaccine Development and Evaluation

  • Immunisation of Special Risk Groups

  • Socio Political Implications of Vaccination and Vaccine Policy

  • Vaccines against Mosquito and Tick Borne Diseases

  • Veterinary Vaccines

  • Vaccines against Respiratory Diseases (Influenza/Covid)

  • Vaccine Hesitancy

  • Vaccines for Neglected Diseases

  • RSV

  • Mpox

  • Vaccine Durability/Memory/adjuvants

  • Hot Topics

You can submit as many abstracts to the conference for review as you would like.  If, after the review by the committee, you have more than one paper accepted for the conference, you will need to register to attend and pay an additional paper fee for each additional paper (i.e., for the 2nd, 3rd, 4th papers – not the 1st). Please note this is for papers that you are the presenting author of, not papers that you are co-author of.

Successfully submitted abstracts will be acknowledged with an electronic receipt including an abstract reference number, which should be quoted in all correspondence. Allow at least 2 hours for your receipt to be returned to you.

For revisions or queries regarding papers already submitted

For revisions or queries regarding abstracts already submitted please contact the Conference Content Executive opens in new tab/window, (please do not email credit card information under any circumstances). If you do not receive acknowledgement for your abstract submission or you wish to make any essential revisions to an abstract already submitted, please DO NOT RESUBMIT your abstract, as this may lead to duplication. Please email the Conference Content Executive opens in new tab/window (please do not email credit card information under any circumstances) with details of any revisions or queries. Please quote your reference number if you have one. A condition of submission is that if accepted one of the authors will present at the conference.